Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77018, internally assigned NDC 99000-9278-64
FDA recall notice · announced June 5, 2024 · Revive Rx Llc Dba Revive Rx Pharmacy
Class I FDA/FSIS Class I: reasonable probability that use will cause serious adverse health consequences or death.
The product
Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77018, internally assigned NDC 99000-9278-64
Reason for recall
Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate
Notes
Distribution: USA Nationwide
Lot/code information: Lot #: 748127, Exp 9/24/2024
Quantity: 751 vials
Status: Ongoing
Products in this recall event:
- Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77018, internally assigned NDC 99000-9278-64 (D-0511-2024)
Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.